A Greer couple is hosting a fundraiser to support a costly gene editing procedure for their two children, who suffer from a ...

YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the ...

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

A recent review published in Genes & Diseases by researchers from the Naval Medical University and the 922nd Hospital of the Joint Service Support Force of the PLA provides a comprehensive overview of ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...

CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and ...

Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.

Researchers in Australia have led a first-in-human trial for a breakthrough gene-editing therapy that halves bad cholesterol ...